ESYJY$4.9854
Nancal Technology Co Ltd
UnclassifiedRules
30-day price · ESYJY+2.78 (+55.9%)
Low$4.57High$7.75Close$7.75As of26 Jun, 00:00 UTC
Profile
CompanyNancal Technology Co Ltd
TickerESYJY.O
SectorUnclassified
BusinessUnclassified
Industry groupUnclassified
IndustryUnclassified
AI analysis
Business. Nancal Technology Co Ltd is a company primarily engaged in the production and sale of consumer electronics and related products.
Classification. The company is currently unclassified in terms of industry, business sector, and economic activity, with a classification confidence of 0.20 based on rule-based classification.
Key takeaways
- Nancal Technology Co Ltd is engaged in the production and sale of consumer electronics and related products.
- The company is currently unclassified in terms of industry, business sector, and economic activity.
- No financial data is available to assess the company's capital structure, liquidity, profitability, or risk profile.
- Growth trajectory and recent events cannot be evaluated due to the absence of relevant data.
- The company's market price is reported at 4.98 CNY, but no valuation or liquidity metrics are available for further analysis.
Financial snapshot
PeriodLatest reported
CurrencyCNY
Revenue—
Gross profit—
Operating income—
Net income—
R&D—
SG&A—
D&A—
SBC—
Operating cash flow—
CapEx—
Free cash flow—
Total assets—
Total liabilities—
Total equity—
Cash & equivalents—
Long-term debt—
Valuation
Market price$4.98
Market cap—
Enterprise value—
P/E—
Reported non-GAAP P/E—
EV/Revenue—
EV/Op income—
EV/OCF—
P/B—
P/Tangible book—
Tangible book—
Net cash—
Current ratio—
Debt/Equity—
ROA—
ROE—
Cash conversion—
CapEx/Revenue—
SBC/Revenue—
Asset intensity—
Dilution ratio—
Risk assessment
Dilution riskUnknown
Liquidity riskUnknown
- Risk could not be assessed: no financial snapshot, source documents, or observations were available for this run.
Industry benchmarks
Activity: Unclassified · cohort 1 companies
MetricESYJYActivity
Op margin—20.3% medp25 20.3% · p75 20.3%
Net margin—14.0% medp25 14.0% · p75 14.0%
Gross margin—38.3% medp25 38.3% · p75 38.3%
R&D / revenue—11.6% medp25 9.4% · p75 11.6%
CapEx / revenue—8.2% medp25 8.2% · p75 8.2%
Debt / equity—86.4% medp25 86.4% · p75 86.4%